IDT Buys VH Bio’s Oligo Business
Growth in United Kingdom integral to IDT’s European expansion
20-Mar-2009
- United Kingdom
IDT and VH Bio have also announced an agreement to work together to grow IDT’s oligonucleotide business in the UK. The two companies will combine efforts to introduce IDT’s market-leading products to scientists throughout the country.
IDT officially opened its European synthesis facility in Leuven in September 2008, and now has branches in both the UK and Germany.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.